| Literature DB >> 29284053 |
Clara Atterby1, Stefan Börjesson2, Sofia Ny3,4, Josef D Järhult1,5, Sara Byfors3, Jonas Bonnedahl6,7,8.
Abstract
ESBL-producing bacteria are present in wildlife and the environment might serve as a resistance reservoir. Wild gulls have been described as frequent carriers of ESBL-producing E. coli strains with genotypic characteristics similar to strains found in humans. Therefore, potential dissemination of antibiotic resistance genes and bacteria between the human population and wildlife need to be further investigated. Occurrence and characterization of ESBL-producing E. coli in Swedish wild gulls were assessed and compared to isolates from humans, livestock and surface water collected in the same country and similar time-period. Occurrence of ESBL-producing E. coli in Swedish gulls is about three times higher in gulls compared to Swedish community carriers (17% versus 5%) and the genetic characteristics of the ESBL-producing E. coli population in Swedish wild gulls and Swedish human are similar. ESBL-plasmids IncF- and IncI1-type carrying ESBL-genes blaCTX-M-15 or blaCTX-M-14 were most common in isolates from both gulls and humans, but there was limited evidence of clonal transmission. Isolates from Swedish surface water harbored similar genetic characteristics, which highlights surface waters as potential dissemination routes between wildlife and the human population. Even in a low-prevalence country such as Sweden, the occurrence of ESBL producing E. coli in wild gulls and the human population appears to be connected and the occurrence of ESBL-producing E. coli in Swedish gulls is likely a case of environmental pollution.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29284053 PMCID: PMC5746268 DOI: 10.1371/journal.pone.0190380
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of ESBL-producing Escherichia coli in wild gulls habituating in Swedish urban environments in 2012.
Susceptibility to ampicillin (Am), ciprofloxacin (Ci), nalidixic acid (Nal), gentamycin (Gm), streptomycin (Sm), tetracycline (Tc), flophenicol (Ff), colistin (Cs), sulfamethoxazole (Su), trimethoprime (Tm), chloramphenicol (Cm), kanamycin (Km), cefotaxim (Ctx) and ceftazidime (Caz), and was determined by microdilution. Susceptibility to, cefoxitin (Fox), tobramycin (Nn), piperacillin/Tazobactam (Tzp), amoxicillin/Clavulanic acid (AmC), tigecycline (Tgc), nitrofurantoin, meropenem, amikacin, Ertapenem and imipenem was determined by disc diffusion. Susceptibility to fosfomycin was determined by E-test. Epidemiological cut-off values for resistance according to EUCAST (www.eucast.org). All isolates were resistant to ampicillin and cefotaxime.
| City | β-lactamase gene | MLST type | Antibiotic resistance | Replicon type | Resistance |
|---|---|---|---|---|---|
| (pMLST of IncI1) | transformants | ||||
| Malmö | ST681 | AmC, Caz | |||
| Malmö | Tc, Sm, Su, Tm | IncFIB/FII | Tc, Su, Su, Tm | ||
| Malmö | ST10 | Ci, Tc | |||
| Malmö | ST10 | Ci, Tm, Nal, Tc | IncI1 (pST3) | - | |
| Malmö | ST10 | Ci, Tc, Caz | |||
| Malmö | ST3268 | Ci, Sm, Su, AmC, Caz | Ci, Su, Tm | ||
| Malmö | ST540 | Ci, Sm, Su, Tm, Tc, AmC, Caz | - | ||
| Malmö | ST93 | Ci, Tm, Nal, Tc, Caz | IncFIA, IncFIB | Tc, Tm | |
| Malmö | ST681 | AmC, Caz | |||
| Malmö | ST58 | Nal, Tc, Gm, Nn, Ci, AmC, Caz | IncFIA/FIB/FII | Ci, Gm, Tc | |
| Malmö | ST58 | Ci, Nal, Tc, Gm, AmC, Caz | IncFIA/FIB/FII | Ci, Gm, Tc | |
| Malmö | ST10 | - | |||
| Malmö | ST10 | Nal, Tc, Gm, Caz | |||
| Gothenburg | ST617 | Ci, Su, Tm, Nal, AmC, Caz | |||
| Gothenburg | ST155 | Ci, Ff, Sm, Su, Km, Tm, Nal, Tc, Cm, Gm, Nn, AmC, Caz | IncFIB/FII | Gm, Tc, Su, Tm | |
| Gothenburg | Ci, Ff, Su, Tgc, Tc, Cm, Gm, AmC | IncHI1 | Ci, Ff, Gm, Tc, Su, Cm | ||
| Gothenburg | ST767 | Ci, Sm, Su, Km, Tm, Nal, Tc, Cm, Gm, AmC, Caz | IncI1 (pST175) | - | |
| Gothenburg | ST540 | Ci, Sm, Su, Tm, Tc, AmC | Ci | ||
| Gothenburg | ST155 | Ci, Caz | IncK | Ci | |
| Gothenburg | Ci, Su, Cm, AmC | Ci, Su, Cm | |||
| Gothenburg | ST10 | Ci, Km, Nal, Gm, Nn, Fox, Caz, Tzp, AmC | - | ||
| Gothenburg | ST10 | Ci, Su, Tm, Nal, Tc, AmC | IncBO | - | |
| Gothenburg | ST131 | Ci, Sm, Su, Km, Tm, Nal, Tc, Gm, Nn, AmC, Caz | |||
| Gothenburg | ST38 | Ci, Sm, Su, Tm, Nal, AmC, Caz | |||
| Gothenburg | ST38 | Ci, Sm, Su, Tm, Nal, AmC | |||
| Gothenburg | Tm, Nal, Tc, Cm, Gm, Nn, Tzp, AmC, Caz | ||||
| Gothenburg | ST636 | Tm, Nal, Tc, AmC, Caz | |||
| Gothenburg | ST58 | Nal, AmC, Caz | |||
| Gothenburg | ST155 | Tc, Cm, Gm, AmC |
aNon-transferable with transformation.
bNon-typable using PCR-based plasmid replicon typing.
cTransformation and replicon typing was not performed.
dMicrodilution was not performed.
eThe recipient cell ElektroMax ™ DH108 ™ (Gibco Invitrogen) naturally resistant to streptomycin.
Fig 1Frequency of overlapping ESBL genes in Swedish gulls (current study), community carriers, bloodstream infections, poultry, pigs/calves (Börjesson et al. [11]) and surface waters (Egervärn et al. [12]).
Fig 2Frequency of overlapping plasmid replicon types containing ESBL genes in Swedish gulls (current study), community carriers, bloodstream infections, poultry, pigs/calves (Börjesson et al. [11]) and surface waters (Egervärn et al. [12]).
Number (%) of overlap plasmid-replicon type /gene combination in ESBL-producing E. coli isolates from Swedish gulls (current study), community carriers, bloodstream infections, poultry, pigs/calves (Börjesson et al. [11]) and surface water (Egervärn et al. [12]).
| Plasmid | Gene variant in plasmid | Swedish gulls (n = 25) | Community carriers (n = 97) | Bloodstream infections (n = 361) | Swedish surface water (n = 27) | Swedish calf/pig (n = 8) |
|---|---|---|---|---|---|---|
| 1 (4) | 8 (8) | 13 (3) | 2 (7) | 1 (9) | ||
| 1 (4) | - | - | 2 (7) | - | ||
| 1 (4) | 6 (6) | 44 (11) | 1 (4) | - | ||
| 1 (4) | 1 (1) | 2 (0.5) | - | - | ||
| 1 (4) | - | 5 (1) | - | - | ||
| 1 (4) | 8 (8) | 31 (8) | - | - | ||
| 1 (4) | - | 3 (1) | - | - |
Fig 3Frequency of multi-locus sequence types (MLST) in ESBL producing E. coli isolates from Swedish gulls (current study), community carriers, bloodstream infections, poultry, pigs/calves (Börjesson et al. [11]) and surface waters (Egervärn et al. [12]).